Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
McKinsey
Queensland Health
Harvard Business School
QuintilesIMS
Deloitte
Colorcon
UBS

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,314,447

« Back to Dashboard

Summary for Patent: 9,314,447
Title:Reduced dose pharmaceutical compositions of fenofibrate
Abstract: The present invention provides a reduced dose oral pharmaceutical composition comprising mixture of nanoparticulate fenofibrate and micronized fenofibrate and one or more pharmaceutically acceptable excipients.
Inventor(s): Kallem; Venkat Reddy (Hyderabad, IN), Kasu; Raghu Rami Reddy (Maharashtra, IN), Das; Subhasis (Maharashtra, IN), Thommandru; Vijaya Kumar (Maharashtra, IN)
Assignee: Lupin Atlantis Holdings, S.A. (Schaffhausen, CH)
Application Number:13/854,389
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

Drugs Protected by US Patent 9,314,447

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Lupin Atlantis ANTARA (MICRONIZED) fenofibrate CAPSULE;ORAL 021695-005 Oct 18, 2013 RX Yes No ➤ Sign Up ➤ Sign Up Y TREATING SEVERE HYPERTRIGLYCERIDEMIA ➤ Sign Up
Lupin Atlantis ANTARA (MICRONIZED) fenofibrate CAPSULE;ORAL 021695-005 Oct 18, 2013 RX Yes No ➤ Sign Up ➤ Sign Up Y TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,314,447

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India1397/KOL/2012Dec 11, 2012

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKinsey
Farmers Insurance
Moodys
Daiichi Sankyo
Accenture
Medtronic
Johnson and Johnson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.